{"filing":{"accession_number":"0001472375-26-000172","cik":"0001357878","ticker":"RGPX","company_name":"REGENEREX PHARMA, INC.","form":"8-K","filing_date":"2026-06-18","report_date":null,"primary_document":"ixform8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1357878/000147237526000172/ixform8k.htm"},"events":[{"id":12484,"run_id":11059,"accession_number":"0001472375-26-000172","anchor_item_number":"8.01","event_type":"material_litigation","event_domain":"legal","is_material":true,"confidence":0.95,"summary":"Regenerex Pharma commenced litigation against Optimize Health Partners, LLC (owned by the Company's former CFO Kenneth W. Perry) seeking recovery of approximately $37,285 in overbilled amounts plus additional damages, restitution, and injunctive relief. The complaint alleges material breaches of a software license agreement including improper invoice inflation, unauthorized markups, failure to deposit escrow materials, and failure to maintain required insurance—all involving mission-critical healthcare software infrastructure. This is a material litigation disclosure under Item 8.01 that would affect a reasonable investor's assessment of the registrant's financial exposure and operational risks.","company_name":"REGENEREX PHARMA, INC.","ticker":"RGPX","filing_date":"2026-06-18","form":"8-K","submitted_at":null,"items":[{"id":9344,"accession_number":"0001472375-26-000172","item_number":"8.01","item_title":"Other Events","event_type":"material_litigation","event_domain":"legal","is_material":true,"confidence":0.95,"reasoning":"Regenerex Pharma commenced litigation against Optimize Health Partners, LLC (owned by the Company's former CFO Kenneth W. Perry) seeking recovery of approximately $37,285 in overbilled amounts plus additional damages, restitution, and injunctive relief. The complaint alleges material breaches of a software license agreement including improper invoice inflation, unauthorized markups, failure to deposit escrow materials, and failure to maintain required insurance—all involving mission-critical healthcare software infrastructure. This is a material litigation disclosure under Item 8.01 that would affect a reasonable investor's assessment of the registrant's financial exposure and operational risks.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T10:01:08.351308+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":9344,"accession_number":"0001472375-26-000172","item_number":"8.01","item_title":"Other Events","event_type":"material_litigation","event_domain":"legal","is_material":true,"confidence":0.95,"reasoning":"Regenerex Pharma commenced litigation against Optimize Health Partners, LLC (owned by the Company's former CFO Kenneth W. Perry) seeking recovery of approximately $37,285 in overbilled amounts plus additional damages, restitution, and injunctive relief. The complaint alleges material breaches of a software license agreement including improper invoice inflation, unauthorized markups, failure to deposit escrow materials, and failure to maintain required insurance—all involving mission-critical healthcare software infrastructure. This is a material litigation disclosure under Item 8.01 that would affect a reasonable investor's assessment of the registrant's financial exposure and operational risks.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T10:01:08.351308+00:00","company_name":"REGENEREX PHARMA, INC.","ticker":"RGPX","filing_date":"2026-06-18"}]}